Patent rejected for MNC’s cancer drug, generics to follow
NEW DELHI: In what could be good news for patients, Indian Patent Office (IPO) has rejected MNC AbbVie’s patent application for its blockbuster cancer drug Venetoclax citing lack of inventive…
Zydus brings world’s first Nivolumab biosimilar to India
Zydus Lifesciences Limited announced that it has launched the world’s first biosimilar of the cancer immunotherapy drug Nivolumab in India. This marks a major step toward improving access to advanced…
Dr Reddy’s set to start selling generic Ozempic in India at potentially half price
The prices of Ozempic in India can potentially halve to ₹3,600 after Dr. Reddy’s and its ilk start producing the generic version of semaglutide, Nomura says. Dr Reddy’s Laboratories Ltd. is…
A total of 167 drug samples flagged as ‘not of standard quality’ in December 2025: Health Ministry
The list of NSQ and spurious drugs is put up on the CDSCO portal on a monthly basis as part of routine regulatory surveillance activity “As many as 167 drug…
Union Minister Anupriya Patel launches NBEMS online AI training programme for doctors
New Delhi: Union Minister of State for Health and Family Welfare, Smt. Anupriya Patel, today launched an online training programme on Artificial Intelligence (AI) in Medical Education developed by the…
English alphabets can’t be trademarked: Delhi HC
New Delhi: The Delhi High Court recently held that English alphabets cannot be monopolised through trademark law and refused interim protection to the mark ‘A TO Z’ used by a pharmaceutical…
IIT Roorkee develops next-generation antibody discovery platform
Dehradun: In a significant step towards affordable healthcare, pandemic preparedness, and indigenous biotechnology innovation, the Indian Institute of Technology Roorkee (IIT Roorkee) has developed a next-generation antibody discovery platform with…
CDSCO approves highest number of new drugs with r-DNA origin for import & manufacture in 2025
The Indian drug regulator has approved the highest number of new drugs based on r-DNA origin, both for imports and manufacturing in the country during the year 2025, compared to…
Spiralling Gold And Silver Prices Impact Costs Of Ayurvedic Medicines With Traces Of Precious Metals
Ayurvedic medicines containing gold, silver and pearl ash were once the most sold, but now their sales have declined by almost 65%. Ajmer: The spiralling prices of gold and silver…
Chhattisgarh eyes investments with high-incentive policy and dedicated pharma park
The state has garnered investment commitments worth Rs 7.83 lakh crore across sectors including pharma, healthcare and allied sectors Chhattisgarh is stepping up efforts to position itself as a leading…
